Rise in Serum Cr ≥ 0.3 mg/dL within 48h, OR rise ≥ 1.5× baseline within 7d, OR Urine output < 0.5 mL/kg/h for ≥ 6h
Prerenal: BUN/Cr > 20:1, FeNa < 1%, UNa < 20, UOsm > 500; ATN: BUN/Cr < 15:1, FeNa > 2%, UNa > 40, UOsm < 350
Loop/thiazide diuretics force natriuresis (falsely elevating FeNa); order FeUrea (< 35% = Prerenal; > 50% = Intrinsic ATN)
Muddy brown granular = ATN; WBC / Eosinophils = AIN/Pyelo; RBC = Glomerulonephritis; Waxy = ESRD; Hyaline = Prerenal
Fever (Pyrexia), Rash (Pink), Eosinophiluria/WBC casts (Pee) 7–14d after Pills (PPIs, NSAIDs, β-lactams, Sulfa, Rifampin)
AEIOU: Refractory Acidosis (pH < 7.1), Electrolytes (K+ > 6.5), Ingestions (Li, alcohols, ASA), Overload, Uremia (pericarditis/encephalopathy)
ECG changes (peaked T / wide QRS) → 1st: IV Calcium Gluconate (stabilizes membrane) → 2nd: IV Insulin + Dextrose (shifts K+ into cells)
Kidneys: Sympathetics T10–T11, Parasympathetics Vagus (CN X); Ureters: T10–L2; Bladder: T11–L2 & S2–S4
Prerenal vs. Intrinsic vs. Postrenal AKI Matrix
| Diagnostic Parameter | Prerenal Azotemia | Intrinsic (Acute Tubular Necrosis) | Postrenal (Obstructive) |
|---|---|---|---|
| Pathophysiology | Renal hypoperfusion (dehydration, HF, sepsis) | Tubular epithelial necrosis (ischemic or nephrotoxic) | Bilateral outflow tract obstruction (BPH, stones, tumor) |
| BUN / Creatinine Ratio | > 20:1 (proximal tubule reabsorbs urea) | < 15:1 (damaged tubule cannot reabsorb) | Variable (initially > 20:1, then < 15:1) |
| Fractional Excretion of Sodium (FeNa) | < 1% | > 2% (impaired tubular sodium reabsorption) | > 2% (in chronic obstruction) |
| Urine Osmolality | > 500 mOsm/kg (concentrated) | < 350 mOsm/kg (isosthenuric) | < 350 mOsm/kg |
| Urine Sodium | < 20 mEq/L | > 40 mEq/L | > 40 mEq/L |
| Urine Sediment | Hyaline casts or normal | Muddy brown granular casts, renal tubular cells | Crystals, hematuria, or bland |
Tubular Sodium & Urea Handling in Prerenal Azotemia vs. Intrinsic Acute Tubular Necrosis (ATN)
In Prerenal AKI (true hypovolemia, hemorrhage, or decreased effective arterial blood volume in CHF/cirrhosis), intact renal tubular epithelial cells respond to angiotensin II, aldosterone, and antidiuretic hormone (ADH) by avidly reabsorbing sodium, water, and urea. Consequently, urine sodium is low (UNa <20 mEq/L), fractional excretion of sodium is <1% (FENa <1%), urine osmolality is concentrated (>500 mOsm/kg), and passive proximal tubular urea reabsorption elevates the serum BUN/Creatinine ratio to >20:1 (NOTE: if the patient is taking loop or thiazide diuretics, natriuresis falsely elevates UNa and FENa, so Fractional Excretion of Urea [FEUrea ≤35%] must be used instead!). In contrast, once prolonged ischemia or nephrotoxins cause sloughing of tubular brush-border cells—Intrinsic Acute Tubular Necrosis (ATN)—the injured tubules cannot reabsorb sodium or concentrate urine, yielding UNa >40 mEq/L, FENa >2%, isosthenuric urine osmolality (<350 mOsm/kg), a normal BUN/Cr ratio (10–15:1), and pathognomonic muddy brown granular casts.
Ischemic vs. Nephrotoxic ATN, Acute Interstitial Nephritis (AIN) & Emergency Dialysis (AEIOU)
Ischemic ATN preferentially damages the metabolically demanding straight segment (S3) of the proximal tubule and the thick ascending limb of the loop of Henle in the outer medulla, whereas nephrotoxic ATN affects the proximal convoluted tubule—triggered by aminoglycosides, iodinated contrast, amphotericin B, cisplatin, myoglobinuria (rhabdomyolysis: blood positive on dipstick with zero RBCs on microscopy), or hemoglobinuria. Distinguish ATN from Acute Interstitial Nephritis (AIN)—a Type IV hypersensitivity reaction occurring 5 to 14 days after starting beta-lactams (penicillins/cephalosporins), sulfonamides, NSAIDs, rifampin, or proton pump inhibitors—which presents with fever, maculopapular rash, peripheral eosinophilia, sterile pyuria, white blood cell casts, and eosinophiluria; AIN is treated by stopping the offending drug (plus corticosteroids if renal recovery stalls). Regardless of AKI etiology, emergent hemodialysis is indicated for the refractory AEIOU criteria: Acidosis (pH <7.1), Electrolytes (refractory hyperkalemia >6.5 mEq/L or ECG changes), Ingestions (lithium, methanol, ethylene glycol, salicylates), Overload (diuretic-refractory pulmonary edema), and Uremia (uremic pericarditis, encephalopathy, or platelet bleeding).
Systematic 4-Step Acid-Base Interpretation
| Diagnostic Step | Mathematical Formula & Normal Reference | Interpretation Thresholds | Classic Clinical Etiologies |
|---|---|---|---|
| Step 1: pH & Primary Disorder | Normal arterial pH = 7.35–7.45; PaCO2 = 35–45 mmHg; HCO3- = 22–26 mEq/L | pH <7.35 = Acidemia (HCO3- <22 = metabolic; PaCO2 >45 = respiratory). pH >7.45 = Alkalemia (HCO3- >26 = metabolic; PaCO2 <35 = respiratory) | Mixed acid-base disorder is immediately confirmed if PaCO2 and HCO3- move in OPPOSITE directions |
| Step 2: Serum Anion Gap (AG) | AG = Na+ - (Cl- + HCO3-); Normal = 8–12 mEq/L (correct for hypoalbuminemia: add 2.5 mEq/L per 1 g/dL albumin below 4.0) | AG >12 mEq/L = High Anion Gap Metabolic Acidosis (HAGMA); AG 8-12 = Normal Anion Gap (Hyperchloremic) Metabolic Acidosis (NAGMA) | HAGMA (MUDPILES): Methanol, Uremia, DKA/Alcoholic/Starvation ketoacidosis, Propylene glycol/Paraldehyde, INH/Iron, Lactic acidosis, Ethylene glycol, Salicylates. NAGMA (HARDASS): Hyperalimentation, Addison, RTA, Diarrhea, Acetazolamide, Spironolactone, Saline |
| Step 3: Winters Formula (Compensation) | Expected PaCO2 = 1.5 x [HCO3-] + 8 (+/- 2) | Actual PaCO2 > Expected = concomitant Primary Respiratory Acidosis; Actual PaCO2 < Expected = concomitant Primary Respiratory Alkalosis | Salicylate toxicity classically produces a mixed Primary Respiratory Alkalosis (direct medullary stimulation) + Primary HAGMA |
| Step 4: Delta-Delta Ratio & Urine AG | Delta AG / Delta HCO3- = (AG - 12) / (24 - HCO3-); Urine AG = (Urine Na+ + Urine K+) - Urine Cl- | Delta ratio <1.0 = HAGMA + concomitant NAGMA; Delta ratio 1.0–2.0 = pure HAGMA; Delta ratio >2.0 = HAGMA + concomitant Metabolic Alkalosis | In NAGMA, a NEGATIVE Urine Anion Gap (high urinary NH4Cl excretion) indicates GI bicarbonate loss (diarrhea; 'neGUTive'), whereas a POSITIVE Urine AG indicates impaired renal acid excretion (Distal Type 1 or Type 4 RTA) |
Step 1: Determine Primary Process
Step 2: Check Anion Gap (If Metabolic Acidosis)
Step 3: Calculate Winter's Formula for Compensation
Step 4: Check Delta-Delta (In HAGMA)
Osmolal Gap Integration for Toxic Alcohol Ingestions (Methanol vs. Ethylene Glycol vs. Isopropanol)
When evaluating a patient with a severe High Anion Gap Metabolic Acidosis (HAGMA) and altered mental status, calculate the Serum Osmolal Gap = Measured Serum Osmolality minus Calculated Osmolality, where Calculated Osmolality = 2 × [Na+] + (Glucose / 18) + (BUN / 2.8) + (Ethanol / 4.6). An Osmolal Gap >10 mOsm/kg accompanied by HAGMA indicates acute ingestion of a toxic alcohol metabolized by alcohol dehydrogenase and aldehyde dehydrogenase into organic acids: Methanol (windshield washer fluid/moonshine) is metabolized to formic acid, causing optic disc hyperemia, visual 'snowstorm,' and blindness plus bilateral putaminal necrosis on CT; Ethylene glycol (antifreeze) is metabolized to glycolic and oxalic acid, causing flank pain, hypocalcemia, cranial neuropathies, acute renal failure, and envelope-shaped calcium oxalate monohydrate crystals in the urine (which fluoresce under Wood lamp if fluorescein was added to antifreeze). Both are treated immediately with Fomepizole (competitive alcohol dehydrogenase inhibitor) and hemodialysis. In contrast, Isopropyl alcohol (rubbing alcohol) is metabolized to acetone (a ketone body, not an organic acid), producing an elevated Osmolal Gap, positive serum/urine ketones, and CNS depression WITHOUT metabolic acidosis (normal pH and normal anion gap).
Saline-Responsive vs. Saline-Resistant Metabolic Alkalosis (Urinary Chloride Cutoffs)
Metabolic alkalosis (pH >7.45, elevated HCO3-, with compensatory hypoventilation increasing PaCO2 by 0.7 mmHg per 1 mEq/L rise in HCO3-) is stratified diagnostically using a spot Urine Chloride (UCl) concentration: (1) Saline-Responsive Metabolic Alkalosis (UCl <20 mEq/L) results from extracellular chloride and volume depletion—classically recurrent vomiting or nasogastric tube suction (loss of gastric HCl plus secondary hyperaldosteronism from hypovolemia) or prior/remote loop or thiazide diuretic use; volume repletion with intravenous 0.9% Normal Saline restores distal chloride delivery and allows the cortical collecting duct pendrin exchanger to excrete bicarbonate. (2) Saline-Resistant Metabolic Alkalosis (UCl >20 mEq/L) reflects autonomous mineralocorticoid excess or ongoing tubular transport defects: if the patient is hypertensive, evaluate for Primary Hyperaldosteronism (Conn syndrome), Cushing syndrome, or Liddle syndrome; if the patient is normotensive, evaluate for Bartter syndrome (thick ascending limb NKCC2 defect mimicking loop diuretics, with hypercalciuria), Gitelman syndrome (DCT NCC defect mimicking thiazides, with hypocalciuria and severe hypomagnesemia), or active surreptitious diuretic abuse.
KDIGO Staging, Glomerular Arteriolar Hemodynamics & FeNa vs. FeUrea
By KDIGO (Kidney Disease: Improving Global Outcomes) criteria, Acute Kidney Injury (AKI) is defined by any of three acute milestones: (1) an increase in serum creatinine by ≥ 0.3 mg/dL within 48 hours, (2) an increase in serum creatinine to ≥ 1.5 times baseline within the prior 7 days, or (3) oliguria defined as urine volume < 0.5 mL/kg/hr for ≥ 6 hours. Understanding how renal autoregulation maintains Glomerular Filtration Rate (GFR) across mean arterial pressures of 80–180 mmHg via afferent arteriolar prostaglandins (PGI2, PGE2) and efferent arteriolar Angiotensin II is essential to diagnosing prerenal versus intrinsic and postrenal injury.
| Hemodynamic Perturbation / Drug | Primary Arteriolar / Tubular Site | Effect on Renal Blood Flow (RBF) | Effect on Glomerular Hydrostatic Pressure (P_GC) & GFR | Filtration Fraction (FF = GFR / RPF) & Clinical Context |
|---|---|---|---|---|
| Prostaglandins (PGE2, PGI2) (Physiologic state) | Dilates Afferent Arteriole | Increases (↑ RBF) | Increases (↑ PGC and ↑ GFR) | No change (↔ FF); protects GFR during volume depletion/hypotension |
| NSAIDs (Ibuprofen, Ketorolac, Naproxen, Indomethacin) | Inhibits COX → Constricts Afferent Arteriole | Decreases (↓ RBF) | Decreases (↓ PGC and ↓ GFR) | No change (↔ FF); precipitates acute prerenal AKI (and papillary necrosis / AIN) |
| Angiotensin II (Low-to-moderate physiologic levels) | Preferentially Constricts Efferent Arteriole (via AT1 receptors) | Decreases (↓ RBF) | Increases (↑ PGC and preserves ↑ GFR) | Increases (↑↑ FF); increases peritubular capillary oncotic pressure (↑ proximal Na+/urea reabsorption) |
| ACE Inhibitors / ARBs (Lisinopril, Losartan) | Blocks Ang II → Dilates Efferent Arteriole | Increases (↑ RBF) | Decreases (↓ PGC and ↓ GFR) | Decreases (↓↓ FF); causes acute bilateral renal failure in bilateral Renal Artery Stenosis |
| Calcineurin Inhibitors (Tacrolimus, Cyclosporine) | Potent Afferent Arteriolar Vasoconstriction (↑ endothelin, ↓ NO) | Decreases (↓ RBF) | Decreases (↓ GFR) | Causes dose-dependent prerenal AKI, hyperkalemia, hypertension, and chronic interstitial fibrosis |
| Postrenal Ureteral Obstruction (Stones, BPH, Cervical CA) | Increases Bowman Space Hydrostatic Pressure (↑↑ PBS) | Decreases late | Opposes filtration → Decreases (↓↓ GFR) | Requires bilateral obstruction (or unilateral in a solitary kidney) to elevate serum creatinine |
Why BUN/Cr Exceeds 20:1 in Prerenal Azotemia (Peritubular Starling Forces)
In prerenal azotemia (hypovolemia, hemorrhage, congestive heart failure, cirrhosis/hepatorenal syndrome), decreased renal perfusion activates the RAAS and sympathetic nervous system. Angiotensin II constricts the efferent arteriole, which preserves GFR while reducing downstream peritubular capillary hydrostatic pressure and increasing Filtration Fraction (FF = GFR / RPF). Because more protein-free fluid is filtered at the glomerulus, the blood entering the peritubular capillaries has a markedly elevated oncotic pressure (πc) and low hydrostatic pressure (Pc). These Starling forces drive avid proximal tubular reabsorption of sodium and water, which passively pulls urea back into the blood. Simultaneously, Antidiuretic Hormone (ADH / vasopressin) inserts aquaporin-2 channels and urea transporters in the medullary collecting duct to further reabsorb water and urea. Because creatinine is freely filtered and actively secreted without ever being reabsorbed, serum BUN rises disproportionately to creatinine, yielding a BUN : Creatinine ratio > 20:1, Urine Osmolality > 500 mOsm/kg, and Urine Na+ < 20 mEq/L.
Calculating FeNa vs. FeUrea (The Diuretic & GI Bleed Board Traps)
The Fractional Excretion of Sodium (FeNa) measures the percentage of filtered sodium excreted in the urine: FeNa (%) = [(UNa × PCr) / (PNa × UCr)] × 100. In prerenal AKI with intact tubular epithelium, aldosterone and Angiotensin II reclaim > 99% of filtered sodium (FeNa < 1%). In intrinsic Acute Tubular Necrosis (ATN), sloughed necrotic tubular cells cannot reabsorb sodium, leaking sodium into the urine (FeNa > 2%). However, if a prerenal patient has received a loop or thiazide diuretic (or has chronic kidney disease or aldosterone deficiency), urinary sodium wasting falsely elevates FeNa > 1%. Because urea reabsorption in the proximal tubule is unaffected by loop/thiazide diuretics, clinicians calculate the Fractional Excretion of Urea (FeUrea): FeUrea < 35% confirms Prerenal AKI, whereas FeUrea > 50% indicates ATN. Also remember that an upper GI bleed elevates BUN/Cr > 30:1 due to intestinal digestion and hepatic urea conversion of blood hemoglobin proteins.
Postrenal Obstructive Uropathy: Bladder Scan, Hydronephrosis & Post-Obstructive Diuresis
Postrenal AKI accounts for 5–10% of cases and is most common in older men with benign prostatic hyperplasia (BPH) or prostate cancer, women with pelvic/cervical malignancy encasing both ureters, patients with retroperitoneal fibrosis (methysergide, IgG4 disease, lymphoma), or neurogenic bladder (anticholinergics, spinal cord injury, multiple sclerosis). Because a single normal kidney can maintain a normal serum creatinine, ureteral stones cause AKI only if there is bilateral ureteral obstruction or obstruction of a solitary functioning kidney (e.g., renal transplant). Initial evaluation starts with Foley urethral catheterization (immediately diagnostic and therapeutic for bladder outlet obstruction, yielding high post-void residual > 200–500 mL) and Renal Ultrasound to detect hydronephrosis. After decompressing severe bilateral obstruction, watch closely for post-obstructive diuresis (polyuria > 200 mL/hr caused by urea osmotic diuresis and tubular ADH resistance), replacing 50% of urine output with 0.45% NaCl to prevent hypovolemic shock and hypokalemia.
Acute Tubular Necrosis (ATN): Ischemic vs. Nephrotoxic & The 3 Clinical Phases
Acute Tubular Necrosis (ATN) is the single most common cause of intrinsic (intrarenal) AKI in hospitalized patients (~85% of intrinsic cases). Resulting from prolonged renal ischemia (untreated prerenal shock, sepsis, cardiopulmonary bypass) or direct endogenous/exogenous nephrotoxins, necrosis and apoptosis of renal tubular epithelial cells cause denudation of the tubular basement membrane. Sloughed necrotic epithelial cells and Tamm-Horsfall mucoprotein Tamm-Horsfall casts physically obstruct the tubular lumen (raising intratubular pressure and reducing GFR) and allow filtrate to back-leak across the denuded basement membrane into the interstitium, producing pathognomonic muddy brown granular casts on urine sediment microscopy.
| ATN Etiology / Nephrotoxin | Most Vulnerable Nephron Segment | Pathophysiologic Mechanism | Signature Clinical / Lab Features | Prevention & Targeted Treatment |
|---|---|---|---|---|
| Ischemic ATN (Sepsis, Hemorrhagic/Cardiogenic Shock) | Straight Segment (S3) of Proximal Tubule & Medullary Thick Ascending Limb (mTAL) | High ATP demand (Na+/K+-ATPase) + poor medullary O2 supply (vasa recta countercurrent exchange) | Follows prolonged hypotension; patchy tubular necrosis with basement membrane rupture (tubulorrhexis) | Restore MAP ≥ 65 mmHg with isotonic crystalloids & norepinephrine |
| Aminoglycosides (Gentamicin, Tobramycin, Amikacin) | Proximal Convoluted Tubule (PCT) | Endocytosed via megalin → accumulates in lysosomes → myeloid bodies & mitochondrial oxidative injury | Non-oliguric AKI developing 5–10 days after initiation; concurrent vestibular/cochlear ototoxicity | Once-daily extended-interval dosing, trough monitoring, hydration |
| Radiocontrast Media (Iodinated CT/Angiography dye) | Proximal Tubule & Outer Medulla | Intense renal medullary vasoconstriction (endothelin/adenosine) + direct hyperosmolar tubular cytotoxicity | Cr rises within 24–48 hours, peaks at 3–5 days, normalizes within 7–10 days (FeNa often < 1% early!) | Pre- & post-procedure IV Isotonic 0.9% Normal Saline; hold metformin & NSAIDs; use low/iso-osmolar contrast |
| Rhabdomyolysis (Myoglobinuria) & Hemolysis (Hemoglobinuria) | Proximal Tubule & Distal Nephron (cast obstruction) | Heme iron free-radical injury + myoglobin precipitates with Tamm-Horsfall protein in acidic urine | Crush injury, statin+fibrate, seizures; Dipstick +Blood with 0 RBCs on microscopy, CPK > 10,000, ↑ K+, ↑ PO43-, ↓ Ca2+ | Aggressive IV 0.9% Normal Saline (titrate urine output > 200 mL/h) ± IV Sodium Bicarbonate (alkalinize urine pH > 6.5) |
| Cisplatin & Ifosfamide, Tenofovir, Heavy Metals (Lead, Mercury) | Proximal Convoluted Tubule | DNA cross-linking & mitochondrial toxicity in PCT cells → Type 2 RTA (Fanconi syndrome) & ATN | Severe renal magnesium and potassium wasting (cisplatin), glucosuria, phosphaturia | Aggressive IV saline hydration + Amifostine (free-radical scavenger for cisplatin) |
| Amphotericin B | Distal Tubule & Afferent Arteriole | Binds tubular membrane cholesterol → forms transmembrane pores → back-leak of H+ and wasting of K+/Mg2+ | Type 1 (Distal) Renal Tubular Acidosis, severe hypokalemia, hypomagnesemia, nephrogenic DI | Use Liposomal Amphotericin B formulation + pre-infusion IV normal saline loading |
| Crystalline Nephropathy (Ethylene Glycol, Uric Acid [TLS], Acyclovir, Methotrexate, Indinavir) | Distal Tubular Lumen | Intratubular precipitation of insoluble crystals obstructing urine flow + direct tubular necrosis | Ethylene glycol: envelope-shaped calcium oxalate crystals + HAGMA + osmolal gap; Acyclovir: needle-shaped crystals | Ethylene glycol: Fomepizole + hemodialysis; TLS: Rasburicase/Allopurinol + IV fluids; Acyclovir/MTX: IV hydration + leucovorin/alkalinization |
Why the S3 Proximal Tubule and mTAL Are Most Vulnerable to Ischemia
On board examinations, ischemic ATN selectively damages two specific nephron segments located in the outer medulla: (1) the straight segment (S3 / pars recta) of the proximal convoluted tubule, and (2) the medullary Thick Ascending Limb (mTAL) of the loop of Henle. This exquisite sensitivity results from a physiological mismatch between oxygen supply and demand: both segments perform massive active ATP-dependent sodium transport via basolateral Na+/K+-ATPase pumps, yet the renal medulla receives < 10% of total renal blood flow and operates at a borderline hypoxic baseline (PO2 ~10–20 mmHg) because oxygen diffuses directly from descending to ascending vasa recta capillaries via countercurrent exchange.
The Three Chronological Phases of ATN (Initiation, Maintenance, Recovery)
Acute Tubular Necrosis progresses through three distinct clinical stages: (1) Initiation Phase (hours to days): the acute ischemic or toxic insult reduces GFR as tubular epithelial cells lose brush borders and polarity; (2) Maintenance (Oliguric) Phase (typically 1 to 3 weeks): GFR stabilizes at its nadir (5–10 mL/min) due to intratubular cast obstruction and afferent arteriolar vasoconstriction triggered by tubuloglomerular feedback (high NaCl delivery to the macula densa constricts the afferent arteriole via adenosine). During this oliguric phase (< 400 mL urine/day), patients are at peak risk for life-threatening volume overload, hyperkalemia, metabolic acidosis, and uremia; and (3) Recovery (Polyuric / Diuretic) Phase: tubular epithelial cells regenerate along the basement membrane, clearing luminal casts and restoring glomerular filtration before the immature regenerating tubular cells regain their capacity to reabsorb sodium, potassium, and water. This produces massive polyuria (3–5+ L/day) with life-threatening hypovolemia, hypokalemia, and hypomagnesemia.
Cholesterol Atheroembolic Renal Disease ('Blue Toe Syndrome') vs. Contrast AKI
A classic board distractor asks you to differentiate Contrast-Induced AKI from Renal Atheroembolic Disease (Cholesterol Crystal Embolization) in an elderly vasculopath who develops renal failure after cardiac catheterization, coronary angiography, or aortic surgery. Contrast nephropathy presents within 24–48 hours of dye exposure with an isolated creatinine bump that resolves within 7 days and lacks systemic signs. Conversely, Cholesterol Atheroembolism occurs when mechanical catheter manipulation scrapes ulcerative aortic atherosclerotic plaques, showering cholesterol crystals into renal arcuate/interlobular arteries and lower-extremity arterioles. It presents days to weeks later with progressive, often irreversible renal failure accompanied by livedo reticularis, 'purple/blue toes' with intact pedal pulses, Hollenhorst retinal plaques, peripheral blood eosinophilia, eosinophiluria, and hypocomplementemia (low C3). Renal biopsy reveals pathognomonic biconvex, needle-shaped clefts within occluded arterioles where cholesterol crystals dissolved during tissue fixation.
Acute Interstitial Nephritis (AIN), Renal Papillary Necrosis & Contrast Prophylaxis
Beyond tubular necrosis, intrinsic AKI includes tubulointerstitial and microvascular disorders that frequently follow medication exposure. Acute Interstitial Nephritis (AIN) is a Type IV (T-cell-mediated delayed) hypersensitivity reaction within the renal interstitium occurring 7 to 14 days after starting a culprit medication, whereas Renal Papillary Necrosis represents ischemic coagulative necrosis of the renal medullary pyramids that slough into the renal pelvis to cause gross hematuria and ureteral colic.
| Intrinsic Renal Syndrome | Classic Etiologies & Mnemonics | Pathogenesis | Clinical Presentation & Urinalysis | Definitive Management |
|---|---|---|---|---|
| Acute Interstitial Nephritis (AIN) | 5 Ps: Pills (Penicillins/Cephalosporins, PPIs [omeprazole], NSAIDs, Sulfonamides [TMP-SMX, furosemide], Rifampin, Allopurinol); Infections (Legionella, Leptospira); Autoimmune (Sjögren, Sarcoidosis, SLE) | Type IV cell-mediated hypersensitivity → interstitial edema with T lymphocytes, macrophages, plasma cells, and eosinophils | 5–14d post-drug: Fever (Pyrexia), maculopapular Rash (Pink), arthralgias, Sterile Pyuria, WBC casts, Eosinophiluria, peripheral eosinophilia (pain-free unless capsule stretches) | Immediately discontinue offending drug; initiate systemic Corticosteroids (prednisone) if renal function fails to improve within 3–5 days |
| NSAID-Induced Minimal Change + AIN | Chronic NSAID use (ibuprofen, naproxen) | T-cell cytokine production causes both interstitial nephritis AND podocyte foot process effacement | Presents with concurrent Acute Kidney Injury (AIN) AND Nephrotic-range proteinuria (> 3.5 g/d); typically lacks fever/rash | Discontinue NSAIDs ± corticosteroids |
| Renal Papillary Necrosis | POSTCARDS: Pyelonephritis, Obstruction, Sickle cell trait/disease, Tuberculosis, Cirrhosis, Analgesic abuse (NSAIDs + acetaminophen/phenacetin), Renal vein thrombosis, Diabetes mellitus, Systemic vasculitis | Ischemia of vasa recta supplying the vulnerable tips of the renal medullary pyramids (papillae) → coagulative necrosis & sloughing | Gross hematuria, acute flank pain (ureteral colic from sloughed necrotic papilla), sterile pyuria, proteinuria; CT urography shows 'ring shadow' in calyx | Stop analgesics/NSAIDs, hydrate, treat infection, relieve ureteral obstruction if sloughed papilla impacts ureter |
| Hepatorenal Syndrome (HRS) | Decompensated cirrhosis with portal hypertension and ascites (often triggered by SBP or GI bleed) | Portal HTN → splanchnic vasodilation (NO) → effective arterial underfilling → intense renal arterial vasoconstriction (structurally normal kidneys!) | Urine Na+ < 10 mEq/L, FeNa < 0.1%, bland urine sediment, fails to improve after holding diuretics for 48h and giving IV Albumin (1 g/kg/d) | Terlipressin + Albumin (or Midodrine + Octreotide + Albumin or Norepinephrine); definitive cure is Liver Transplantation |
| Cortical Necrosis | Obstetric catastrophes (abruptio placentae, septic abortion), septic shock, HUS/DIC | Diffuse microvascular thrombosis + severe cortical vasospasm | Sudden complete anuria (< 50 mL/d), gross hematuria, flank pain; cortical calcification on imaging | Often progresses to permanent end-stage renal disease requiring chronic dialysis |
Acute Interstitial Nephritis (AIN): Clinical Pearls & PPI Association
While the classic triad of Acute Interstitial Nephritis (AIN)—fever, maculopapular rash, and peripheral eosinophilia—is memorable, all three features appear simultaneously in only 10–15% of patients. On board vignettes, always suspect AIN when an inpatient or outpatient develops a rising serum creatinine 1 to 2 weeks after starting a beta-lactam antibiotic (nafcillin, piperacillin, cephalexin), a sulfonamide (TMP-SMX, furosemide, thiazide), an NSAID, or a Proton Pump Inhibitor (omeprazole, pantoprazole). Note that PPI-induced AIN often presents insidiously weeks to months after initiation without fever or rash! Urinalysis is the diagnostic cornerstone, showing sterile pyuria (WBCs with negative bacterial culture), White Blood Cell (WBC) casts (which localize inflammation strictly to the kidney, seen only in AIN and acute pyelonephritis), mild sub-nephrotic proteinuria, hematuria, and eosinophiluria on Hansel or Wright stain.
Renal Papillary Necrosis: The POSTCARDS Differential & Sickle Cell Trait
The renal medulla and papillae exist in a hypertonic, hypoxic microenvironment perfused exclusively by the fragile vasa recta. In analgesic nephropathy (chronic ingestion of NSAIDs combined with acetaminophen or aspirin), NSAIDs block vasodilatory prostaglandins while acetaminophen metabolites deplete glutathione, causing oxidative papillary necrosis and chronic tubulointerstitial nephritis. Similarly, in Sickle Cell Trait (HbAS) as well as Sickle Cell Disease (HbSS), the extreme hypertonicity, hypoxia, and acidosis of the renal medulla induce sickling of erythrocytes within the vasa recta, causing microinfarctions of the renal papillae. Consequently, a young Black patient presenting with painless gross hematuria or flank pain with sloughed tissue and isosthenuria (inability to concentrate urine) has renal papillary necrosis from sickle cell trait until proven otherwise.
Evidence-Based Prophylaxis for Contrast-Associated AKI
When a patient with underlying chronic kidney disease (eGFR < 45–60 mL/min/1.73m2), diabetes mellitus, or heart failure requires an urgent contrast-enhanced study (such as coronary angiography for STEMI or CT angiography for aortic dissection), life-saving imaging should never be withheld. However, three evidence-based preventive measures must be executed: (1) Administer IV Isotonic Crystalloid (0.9% Normal Saline at 1 mL/kg/hr for 6–12 hours pre- and post-procedure) to expand intravascular volume, dilute tubular contrast concentration, and suppress renin/vasopressin; (2) Use the lowest possible volume of iso-osmolar or low-osmolar non-ionic contrast media; and (3) Temporarily hold nephrotoxic medications (NSAIDs, diuretics) and hold Metformin for 48 hours (to prevent metformin-associated Type B lactic acidosis if contrast AKI occurs). Based on the PRESERVE trial, routine oral N-acetylcysteine (NAC) and IV sodium bicarbonate offer no additional benefit over isotonic normal saline.
Refractory Complications, AEIOU Dialysis Indications & Hyperkalemia Protocol
Regardless of the underlying etiology of AKI, every patient must be evaluated immediately for life-threatening metabolic derangements that require medical stabilization or emergent Renal Replacement Therapy (Hemodialysis or Continuous Renal Replacement Therapy [CRRT] in hemodynamically unstable ICU patients). Memorize the five absolute AEIOU indications for emergent dialysis alongside the sequential, mechanism-based pharmacologic ladder for acute hyperkalemia.
| Step / Priority in Hyperkalemia | Pharmacologic Agent & Route | Physiologic Mechanism of Action | Onset & Duration of Effect | Clinical Indication & Board Pearls |
|---|---|---|---|---|
| Step 1: Cardiac Membrane Stabilization | IV Calcium Gluconate (1–2 g over 2–3 min) or Calcium Chloride (via central line) | Directly antagonizes K+-induced membrane depolarization by raising the threshold potential (restores difference between resting & threshold potential); does NOT change serum K+! | Onset: 1–3 minutes; Duration: 30–60 min | MANDATORY FIRST STEP whenever K+ > 6.5 mEq/L OR ANY ECG changes (peaked T waves, loss of P wave, wide QRS, sine wave) |
| Step 2A: Intracellular K+ Shift (Primary) | IV Regular Insulin (10 units) + IV 50% Dextrose (D50W 1 amp / 25 g) | Insulin stimulates basolateral Na+/K+-ATPase in skeletal muscle and hepatocytes, driving extracellular K+ into cells | Onset: 15–30 minutes; Duration: 4–6 hours (lowers K+ by ~0.5–1.2 mEq/L) | Fastest and most reliable intracellular shifting agent; omit D50W only if baseline blood glucose is ≥ 250 mg/dL |
| Step 2B: Intracellular K+ Shift (Adjuncts) | Nebulized high-dose Albuterol (10–20 mg) ± IV Sodium Bicarbonate | Albuterol: β2-adrenergic receptor → cAMP → activates Na+/K+-ATPase; NaHCO3: H+/K+ exchange | Onset: 15–30 minutes; Duration: 2–4 hours | Albuterol is additive with insulin; use IV NaHCO3 ONLY if concomitant severe metabolic acidosis is present |
| Step 3A: Total Body K+ Elimination (Renal/GI) | IV Loop Diuretic (Furosemide) + Patiromer or Sodium Zirconium Cyclosilicate (SZC) | Furosemide increases distal Na+ delivery & kaliuresis; Patiromer/SZC bind K+ in GI lumen in exchange for Ca2+/Na+ | Onset: 1–6 hours | Eliminates K+ from body (shifting agents only hide K+ temporarily); avoid Kayexalate + sorbitol due to colonic necrosis |
| Step 3B: Definitive Extracorporeal Removal | Emergent Hemodialysis | Diffusive clearance of potassium across semipermeable dialyzer membrane against low-K+ dialysate | Immediate upon vascular access; removes 25–50 mEq K+/hr | Indicated for anuric/oliguric AKI, ESRD, massive rhabdomyolysis/TLS, or hyperkalemia refractory to medical therapy |
Chronological ECG Progression of Hyperkalemia vs. Hypokalemia
Extracellular potassium concentration directly governs the resting membrane potential of cardiac myocytes via the Nernst equation. As serum K+ rises above 5.5 mEq/L, the resting membrane potential becomes less negative (partially depolarized), which initially accelerates phase 3 repolarization (via IKr channel activation) before inactivating fast voltage-gated Na+ channels and slowing phase 0 conduction velocity. This produces a strict chronological ECG progression in Hyperkalemia: (1) Tall, narrow-based, symmetric 'peaked' (tented) T waves (K+ 5.5–6.5), (2) Prolonged PR interval and flattening/loss of the P wave (K+ 6.5–7.5), (3) Widening of the QRS complex (K+ 7.0–8.0), and (4) Fusion of the wide QRS and T wave into a sinusoidal 'Sine Wave' pattern (> 8.0) degenerating into ventricular fibrillation or asystole. Conversely, Hypokalemia (K+ < 3.5 mEq/L) causes T-wave flattening/inversion, ST depression, prominent U waves (best seen in leads V2–V3), and pseudo-QT prolongation predisposing to Torsades de Pointes (always replete Magnesium first in refractory hypokalemia!).
The AEIOU Indications for Emergent Hemodialysis & Uremic Platelet Dysfunction
When conservative medical therapy fails in AKI, emergent hemodialysis is initiated for any of the AEIOU criteria: (1) A — Acidosis: severe metabolic acidosis (pH < 7.10) refractory to IV sodium bicarbonate or unable to tolerate sodium/volume load; (2) E — Electrolytes: severe hyperkalemia (K+ > 6.5 mEq/L) refractory to medical shifting/excretion or accompanied by persistent ECG changes; (3) I — Ingestions (Dialyzable Toxins): water-soluble, low-volume-of-distribution, non-protein-bound toxins—memorize Methanol, Ethylene Glycol, Lithium, Salicylates (Aspirin), Theophylline, and Valproate (note: tricyclic antidepressants, digoxin, beta-blockers, and benzodiazepines are NOT dialyzable); (4) O — Overload: diuretic-refractory cardiogenic/pulmonary edema causing hypoxemia; and (5) U — Uremia: symptomatic uremic complications, specifically uremic pericarditis (friction rub, pleuritic pain—heparin-free dialysis is mandatory to prevent hemorrhagic tamponade!), uremic encephalopathy (asterixis, confusion, seizures), or refractory uremic bleeding. Uremic bleeding is caused by guanidinosuccinic acid impairing platelet GP IIb/IIIa aggregation and adhesion (prolonged bleeding time with normal platelet count, normal PT, and normal aPTT); treat acutely with DDAVP (Desmopressin), which releases von Willebrand factor and Factor VIII from endothelial Weibel-Palade bodies.
Non-Anion Gap Metabolic Acidosis (NAGMA) & Urine Anion Gap (RTA vs. Diarrhea)
When evaluating a patient with Normal Anion Gap (Hyperchloremic) Metabolic Acidosis (NAGMA, Anion Gap 8–12 mEq/L)—remembered by HARDASS (Hyperalimentation/0.9% NS, Acetazolamide/Addison disease, Renal Tubular Acidosis, Diarrhea, Uteroenterostomy, Spironolactone, Saline)—the next diagnostic step is calculating the Urine Anion Gap (UAG) = (UNa + UK) − UCl to estimate urinary ammonium (NH4+) excretion. In Lower GI Diarrhea (bicarbonate lost in stool), healthy kidneys compensate by excreting abundant NH4Cl, raising urinary chloride above Na++K+ and yielding a NEGATIVE Urine Anion Gap ('NeGUTive'). Conversely, in Renal Tubular Acidosis (RTA), impaired renal acid excretion prevents NH4Cl synthesis, yielding a POSITIVE Urine Anion Gap: Type 1 (Distal) RTA (alpha-intercalated H+-ATPase failure: urine pH > 5.5, hypokalemia, calcium phosphate kidney stones, Sjögren/amphotericin), Type 2 (Proximal) RTA (PCT HCO3- reabsorption defect: urine pH < 5.5 once serum HCO3- drops, hypokalemia, Fanconi syndrome/multiple myeloma/acetazolamide), and Type 4 RTA (hyporeninemic hypoaldosteronism in diabetes/ACEi/spironolactone/TMP-SMX: urine pH < 5.5 with HYPERKALEMIA).
Renal, Ureteral & Bladder Viscerosomatics, Chapman Points & Psoas Mechanics
Autonomic Innervation (Kidneys, Ureters & Bladder): Board examinations heavily test the precise autonomic transition across the genitourinary tract: (1) Kidneys & Upper Ureters: Sympathetic preganglionic fibers originate from T10–T11 (lesser splanchnic nerve → aorticorenal and superior mesenteric ganglia), increasing renal vascular resistance and stimulating juxtaglomerular beta-1 renin release; parasympathetic fibers derive from the Vagus nerve (CN X). (2) Lower Ureters: Sympathetics from T12–L2; parasympathetics from Pelvic Splanchnic nerves (S2–S4). (3) Urinary Bladder: Sympathetics (T11–L2 via hypogastric nerve) relax the detrusor (β3) and contract the internal urethral sphincter (α1) to promote urinary storage; parasympathetics (S2–S4) contract the detrusor (M3) to promote urination.
Chapman Reflex Points: Kidney = 1 inch superior and 1 inch lateral to the umbilicus anteriorly (posterior: T12–L1 intertransverse space); Adrenal = 2 inches superior and 1 inch lateral to the umbilicus (posterior: T11–T12); Bladder = periumbilical region anteriorly (posterior: upper edge of L2 transverse process).
Psoas Syndrome & OMT: Because the kidneys and ureters rest directly on the iliopsoas fascia, nephrolithiasis or pyelonephritis triggers acute ipsilateral psoas spasm (flexed posture, positive Thomas test, L1–L2 Type II somatic dysfunction). Treat with rib raising (T10–T11) to reduce sympathetic renal vasoconstriction and psoas counterstrain (F SIpsiRContra).
- Trap: Relying on Fractional Excretion of Sodium (FeNa < 1%) to diagnose prerenal azotemia in a patient who recently received furosemide or hydrochlorothiazide. Diuretics block tubular sodium reabsorption, raising urine sodium > 40 mEq/L and FeNa > 1% even in severe volume depletion. Always calculate Fractional Excretion of Urea (FeUrea < 35%) instead.
- Trap: Selecting IV Regular Insulin + Dextrose, Sodium Bicarbonate, or Kayexalate/Patiromer as the first medication in a hyperkalemic patient (K+ 7.2 mEq/L) with peaked T waves, flattened P waves, or widened QRS complex. Always administer IV Calcium Gluconate (or Calcium Chloride) FIRST to immediately stabilize the resting cardiac membrane potential and prevent ventricular fibrillation.
- Trap: Prescribing a 'triple whammy' of an NSAID (ibuprofen/ketorolac) + an ACE inhibitor/ARB + a diuretic in a volume-depleted or CKD patient. NSAIDs block prostaglandin-mediated afferent arteriolar dilation while ACEi/ARBs block angiotensin II-mediated efferent arteriolar constriction, collapsing intraglomerular hydrostatic pressure and GFR.
- Trap: Diagnosing hepatorenal syndrome or prerenal azotemia in an elderly male with benign prostatic hyperplasia (BPH) or neurogenic bladder without first performing a bedside bladder scan / Foley catheterization and renal ultrasound to rule out postrenal obstructive uropathy.
- Trap: Administering sodium polystyrene sulfonate (Kayexalate) mixed with sorbitol to a postoperative or ileus patient (causes colonic intestinal necrosis), or relying on oral N-acetylcysteine or prophylactic sodium bicarbonate rather than simple isotonic IV 0.9% Normal Saline for contrast-associated AKI prophylaxis.
- Trap: Confusing rhabdomyolysis myoglobinuria with true hematuria on urinalysis. Both myoglobin and hemoglobin turn the urine dipstick 3+ positive for 'Blood' (pseudoperoxidase reaction), but rhabdomyolysis shows 0–2 RBCs/hpf on microscopy, pigmented granular casts, CPK > 10,000 U/L, hyperkalemia, hyperphosphatemia, and hypocalcemia.